Drugs / 5-grasses
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT02423707 Comparator | Aug 2010 → Nov 2015 | allergic rhinitis | Karolinska Institutet | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-grasses | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02423707 ↗ |
| Known as | ALK-alutard SQ 5-grasses | “The substance used for the three intralymphatic injections is ALK-alutard SQ Betula verrucosa® and ALK-alutard SQ 5-grasses ® under ATC-code V01AA, V04CL and V07AB which is a...” NCT02423707 ↗ |
| Route | Other | “intralymphatic injections” NCT02423707 ↗ |